NCT01391520View on ClinicalTrials.gov

Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent

PHASE3WithdrawnINTERVENTIONAL

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

June 30, 2013

Conditions

Acute Kidney Injury

Interventions

DRUG

deferiprone

3 tablets (treatment arm assigned in double-blind, randomized manner) will be given every 12 hours for a total of 8 days, beginning 1-3 hours prior to angiography

DRUG

Placebo

3 tablets (treatment arm assigned in double-blind, randomized manner) will be given every 12 hours for a total of 8 days, beginning 1-3 hours prior to angiography